Teresa L. Knight, MD, FACOG, Chief Medical Officer of the Women’s Health Specialists of Saint Louis, discusses menopause and hormone replacement therapy. To learn more about the Women’s…
NEW YORK (Reuters Health) -In the emergency department, a standardized protocol of hydromorphone administration is more efficacious than usual care for controlling acute severe pain, a team at…
NEW YORK (Reuters Health) – A Danish observational study provides no evidence that use of angiotensin receptor blockers (ARBs) is associated with an increased risk of incident cancer…
NEW YORK (Reuters Health) – Results of an integrated analysis of pooled data from two clinical trials confirm that the recombinant peptide ecallantide (Kalbitor; Dyax Corp) reduces symptoms…
NEW YORK (Reuters Health) – Patients undergoing percutaneous coronary interventions who receive high-dose statin treatment before the procedure have about half the rate of major adverse cardiac events…
NEW YORK (Reuters Health) – The combination of etanercept and cyclophosphamide might be a risky one in patients with Wegener’s Granulomatosis, especially with those who have long-term, chronic…
NEW YORK (Reuters Health) – A study from China indicates that vardenafil has favorable effects in patients with pulmonary arterial hypertension (PAH). Dr. Zhi-Cheng Jing, at Tongji University…
NEW YORK (Reuters Health) – Outcomes among tuberculosis patients treated with a fixed-dose combination of four drugs are similar to those in patients treated with the same four…
NEW YORK (Reuters Health) – There is some evidence to support the use of immunosuppressive therapy to avoid relapse in inflammatory bowel disease (IBD), but more research is…
NEW YORK (Reuters Health) – Bosentan is not an effective therapy for patients with idiopathic pulmonary fibrosis (IPF), suggests a new study organized by the company that makes…